Recent news on Lotronex

Why Are Millions Taking A Dangerous Anti-Diabetic Drug?  -  25 May 2007
Evening Bulletin,He documents disasters from new drugs such as Lotronex, on the market for less than a year, and pulled off because it was causing serious illness and death.

Drug Safety Proposals and the Intrusion Of Federal Regulation into ...  -  May 11, 2007
American Enterprise Institute,...behavior as new problems emerged around a handful of new drugs, many launched in the 1990s, including Rezulin, Trovan, Propulsid, and Lotronex.

AGS: Geriatricians Go Slow with Newer Chronic Constipation Therapies  -  May 8, 2007
MedPage Today,Another drug that works on the 5-HT receptors, alosetron (Lotronex), was recalled by the FDA in 2000 because of reports of ischemic colitis and severe

Your Drug Gets Pulled -- What Now?  -  Apr 4, 2007
Wall Street Journal (subscription),Another IBS drug from GlaxoSmithKline PLC, Lotronex, is FDA-approved to treat IBS patients who suffer mostly from diarrhea, or IBS-D. When Lotronex was

Novartis Pulls Zelnorm in US, Cuts 2007 Outlook  -  Apr 1, 2007
CNBC,GlaxoSmithKline Plc's irritable bowel drug Lotronex came off the US market in 2000 after some patients experienced severe intestinal problems.

Palio's Rising Star  -  Apr 24, 2007
PharmaLive.com (press release),Her pharmaceutical experience includes launches of Relenza® and Lotronex®, indicated for irritable bowel syndrome. While at GSK, Irish also represented

FDA tells Novartis to stop selling IBS drug Zelnorm over possible ...  -  Apr 2, 2007
Pharma Times (subscription),GlaxoSmithKline may have re-launched Lotronex (alosetron) in the USA in 2002 but under a restricted use label, after it had been withdrawn two years earlier

Bowel drug is withdrawn from market  -  Mar 31, 2007
Seattle Times,The FDA followed a similar approach a few years ago with another drug for irritable-bowel problems, Lotronex. The discovery of possible heart risks followed

FDA asks Novartis to halt sale of drug for bowel ills  -  Mar 30, 2007
Boston Globe,The other was GlaxoSmithKline PLC's irritable bowel drug Lotronex, returned to the market with restrictions in 2002 after a link to patient deaths.

Studies Lead to Withdrawal of Drug for Bowel Ailment  -  Mar 30, 2007
New York Times,When in 2000 the agency forced the withdrawal of Lotronex, another drug for irritable bowel syndrome, it was so inundated by complaints from sufferers that

Drug for Stomach Ills Is Pulled From the Market  -  Mar 30, 2007
New York Times,The agency created something similar for Lotronex, another drug for irritable bowel syndrome, after patients inundated the agency with complaints following

FDA To Novartis: Stop Selling Zelnorm  -  Mar 30, 2007
Forbes,In 2000, the FDA withdrew an irritable bowel drug called Lotronex, from GlaxoSmithKline (nyse: GSK - news - people ). The drug was put back on the market in

That Irritable IBS  -  Feb 6, 2007
YourHub.com,Zelnorm and Lotronex, drugs approved to treat IBS, should be avoided at all costs. IBS is a condition that is 100% treatable by a conservative,

Gastrointestinal Medications  -  Jan 5, 2007
Psychosomatics (subscription)Koch K, Campanella C, Baidoo C, et al: Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex).

Desert Whispers  -  Dec 17, 2006
Arizona Daily Star,Other drugs pulled off the market in recent years were Vioxx, Palladone, Baycol, Posicor, Seldane and Lotronex, to name a few.

Top 10 Stories of 2006 by Harvard Health Letter Picks Key Ones for ...  -  Dec 4, 2006
SeniorJournal.com,Several years ago the agency let Lotronex, the controversial irritable bowel syndrome drug, back on the market, but with restrictions.

Trine Initiates Phase 2b Trial for D-IBS  Oct 29, 2006
The market for D-IBS is largely unserved due to serious toxicities associated with black-box restrictions of GlaxoSmithKline's Lotronex, approved for the ... -Yahoo! News (press release) Top 10 Stories of 2006 by Harvard Health Letter Picks Key Ones for ...  -  Dec 4, 2006
SeniorJournal.com,Several years ago the agency let Lotronex, the controversial irritable bowel syndrome drug, back on the market, but with restrictions.

Garnier’s legacy is a healthier Glaxo  Jul 29, 2006
A long list of much-hyped medicines either failed in late-stage trials or — like Relenza for flu, Lotronex for irritable- bowel syndrome and Levitra for ... -The Sunday Times

Answer to irritable bowels may be in the brain  Jul 30, 2006
Dissatisfaction with the two medications currently approved for IBS – Lotronex and Zelnorm – has led to a resurgence of interest in how patients can help ... -Nashua Telegraph (subscription)

Interest heats up in gastrointestinal space  Jul 7, 2006
The only two drugs that have so far gained US Food and Drug Administration (FDA) approval for treatment of IBS are Lotronex (alosetron), developed by ... -Nature.com (subscription)

Hypnotherapy may help calm irritable bowels  Jun 25, 2006
Dissatisfaction with the two medications currently approved for IBS – Lotronex and Zelnorm – has led to a resurgence of interest in how patients can help ... -Fort Wayne Journal Gazette



Are You Sure You're Feeling OK?  16 May 2006
GlaxoSmithKline's drug Lotronex received FDA approval for treatment of irritable bowel in 2000, and Novartis' Zelnorm was approved in 2002. ... - AlterNet

FDA hearing will focus on safety of RU-486  16 May 2006
In 2000, the FDA pulled Lotronex, a remedy for irritable bowel syndrome, after five patients died in the first seven months after its approval. ... - Myrtle Beach Sun News

Marketing a second dose  May 15, 2006
That company's drug, Lotronex, a treatment for irritable bowel syndrome, was pulled from the market in 2000 after 163 hospitalizations, 51 surgeries and 14 ... - Kentucky.com

Making the Link  May 2, 2006
In 2000, FDA pulled Glaxo's Lotronex (alosetron) from the market. Lotronex, indicated for diarrhea-predominant irritable bowel syndrome ... - PharmExec.com





Better Science, Safer Drugs  Mar 1, 2006
We should also keep in mind that many drugs initially vilified by the media and FDA critics -- Vioxx, Lotronex and thalidomide, to name just a few -- have ... - Human Events

Tysabri, an MS Drug with Potentially Deadly Side-Effects, Gets FDA ...  Feb 18, 2006
Some of the more recent “failures� in the longevity department are: Tysabri – 4 months; Lotronex – 9 months; Duract – 11 months; Posicor – 12 months ... - Newsinferno.com,

FDA Approval of Insulin System is…Sweet…All Hail “Exuberaâ€?  Feb 1, 2006
But then the FDA started to look like a girlfriend to big drug companies, as one drug after another (Rezulin, Lotronex, Vioxx) had to be recalled. ... - Santa Monica Mirror

S&R Communications Group Named Agency of Record for CB Fleet® ...  Jan 23, 2006
Inc) and Canasa ® (Axcan Scandipharm), the irritable bowel syndrome drugs Robinul ® (Wyeth Pharmaceuticals) and Lotronex ® (GlaxoSmithKline), and the ... - PharmaLive.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional